UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

G protein-coupled estrogen receptor 1 (GPER, GPR 30) in normal human endometrium and early pregnancy decidua

Molecular human reproduction, 2010-10, Vol.16 (10), p.743-751

2010

Volltextzugriff (PDF)

Norepinephrine Transporter (NET), Serotonin Transporter (SERT), Vesicular Monoamine Transporter (VMAT2) and Organic Cation Transporters (OCT1, 2 and EMT) in Human Placenta from Pre-eclamptic and Normotensive Pregnancies

Placenta (Eastbourne), 2004-07, Vol.25 (6), p.518-529

2004

Volltextzugriff (PDF)

Endometrial expression of the estrogen-sensitive genes MMP-26 and TIMP-4 is altered by a substitution protocol without down-regulation in IVF patients

Human reproduction (Oxford), 2006-12, Vol.21 (12), p.3146-3156

2006

Volltextzugriff (PDF)

Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle

Molecular human reproduction, 2004-09, Vol.10 (9), p.655-663

2004

Volltextzugriff (PDF)

Matrix metalloproteinase-26 (Matrilysin-2) expression is high in endometrial hyperplasia and decreases with loss of histological differentiation in endometrial cancer

Gynecologic oncology, 2004-09, Vol.94 (3), p.661-670

2004

Volltextzugriff (PDF)

P1020 Cleaved forms of the upa receptor in plasma have diagnostic potential and predict postoperative survival in patients with ovarian cancer

International journal of gynecology and obstetrics, 2009-10, Vol.107 (S2), p.S699-S700

2009

Volltextzugriff (PDF)

Diagnosis of endometrial cancer in patients with postmenopausal bleeding by analysis of the lactate dehydrogenase isoenzyme activity profile in uterine fluid

Gynecologic oncology, 2004-05, Vol.93 (2), p.385-389

2004

Volltextzugriff (PDF)

Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer

European journal of cancer (1990), 2001-12, Vol.37 (18), p.2339-2348

2001

Volltextzugriff (PDF)

Endometrial TIMP-4 mRNA is expressed in the stroma, while TIMP-4 protein accumulates in the epithelium and is released to the uterine fluid

Molecular human reproduction, 2006-08, Vol.12 (8), p.497-503

2006

Volltextzugriff (PDF)

Epithelial expression of matrix metalloproteinase‐26 is elevated at mid‐cycle in the human endometrium

Molecular human reproduction, 2003-05, Vol.9 (5), p.271-277

2003

Volltextzugriff (PDF)

ID: 281 An in vitro model for tumor cell - stromal cell crosstalk in ovarian cancer. Induction of uPA gene expression in stromal cells involves multiple signaling molecules, and is augmented by a 3D extra-cellular matrix

Journal of thrombosis and haemostasis, 2006-10, Vol.4 (s1), p.77-77

2006

Volltextzugriff (PDF)

Plasminogen activators and plasminogen activator inhibitors in blood and tumour fluids of patients with ovarian cancer

European journal of cancer (1990), 1994, Vol.30 (9), p.1302-1309

1994

Volltextzugriff (PDF)

Endometrial TIMP-4 mRNA is high at midcycle and in hyperplasia, but down-regulated in malignant tumours. Coordinated expression with MMP-26

Molecular human reproduction, 2004-09, Vol.10 (9), p.641-650

2004

Volltextzugriff (PDF)

Transvaginal ultrasound and lactate dehydrogenase isoenzyme activity profile in uterine aspirate for diagnosis of endometrial carcinoma in women with postmenopausal bleeding

International journal of gynecological cancer, 2007-11, Vol.17 (6), p.1322-1326

2007

Volltextzugriff (PDF)

Health-related quality of life and functional vision in individuals with retinoblastoma treated with ocular prothesis

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, Vol.64 (8)

2023

Volltextzugriff (PDF)

Human uterine fluid, examined in undiluted samples for osmolarity and the concentrations of inorganic ions, albumin, glucose, and urea

American journal of obstetrics and gynecology, 1984-12, Vol.150 (7), p.877-881

1984

Volltextzugriff (PDF)

Cell membrane receptors for urokinase plasminogen activator are increased in malignant ovarian tumours

European journal of cancer & clinical oncology, 1991-01, Vol.27 (11), p.1445-1448

1991

Volltextzugriff (PDF)

Progesterone regulation of plasminogen activator inhibitor 1 (PAI-1) antigen and mRNA levels in human endometrial stromal cells

Thrombosis research, 1992-04, Vol.66 (1), p.75-87

1992

Volltextzugriff (PDF)

O157 The membrane bound G-protein coupled receptor, GPR30, mediates the anti-invasive effect of estradiol in ovarian cancer cells

International journal of gynecology and obstetrics, 2009-10, Vol.107 (S2), p.S137-S137

2009

Volltextzugriff (PDF)

Soluble receptor for urokinase plasminogen activator in both full-length and a cleaved form is present in high concentration in cystic fluid from ovarian cancer

Cancer research (Chicago, Ill.), 1998-08, Vol.58 (15), p.3294-3298

1998

Volltextzugriff (PDF)

Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI‐1)

International journal of cancer, 2001-05, Vol.92 (4), p.497-502

2001

Volltextzugriff (PDF)

High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI‐2) is an independent marker for shorter progression‐free survival in patients with early stage endometrial cancer

International journal of cancer, 2002-01, Vol.97 (3), p.379-385

2002

Volltextzugriff (PDF)

Fluid characteristics of benign ovarian cysts: correlation with recurrence after puncture

Obstetrics and gynecology (New York. 1953), 1995-10, Vol.86 (4 Pt 1), p.529-535

1995

Volltextzugriff (PDF)

Degradation of urokinase plasminogen activator (UPA) in endometrial stromal cells requires both the UPA receptor and the low-density lipoprotein receptor-related protein/alpha2-macroglobulin receptor

Molecular human reproduction, 1998-06, Vol.4 (6), p.585-593

1998

Volltextzugriff (PDF)

Paracrine Stimulation of Capillary Endothelial Cell Migration by Endometrial Tissue Involves Epidermal Growth Factor and Is Mediated Via Up-Regulation of the Urokinase Plasminogen Activator Receptor

The journal of clinical endocrinology and metabolism, 2001-04, Vol.86 (4), p.1724-1730

2001

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(71)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

G protein-coupled estrogen receptor 1 (GPER, GPR 30) in normal human endometrium and early pregnancy decidua

Norepinephrine Transporter (NET), Serotonin Transporter (SERT), Vesicular Monoamine Transporter (VMAT2) and Organic Cation Transporters (OCT1, 2 and EMT) in Human Placenta from Pre-eclamptic and Normotensive Pregnancies

Endometrial expression of the estrogen-sensitive genes MMP-26 and TIMP-4 is altered by a substitution protocol without down-regulation in IVF patients

Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle

Matrix metalloproteinase-26 (Matrilysin-2) expression is high in endometrial hyperplasia and decreases with loss of histological differentiation in endometrial cancer

P1020 Cleaved forms of the upa receptor in plasma have diagnostic potential and predict postoperative survival in patients with ovarian cancer

Diagnosis of endometrial cancer in patients with postmenopausal bleeding by analysis of the lactate dehydrogenase isoenzyme activity profile in uterine fluid

Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer

Endometrial TIMP-4 mRNA is expressed in the stroma, while TIMP-4 protein accumulates in the epithelium and is released to the uterine fluid

Epithelial expression of matrix metalloproteinase‐26 is elevated at mid‐cycle in the human endometrium

ID: 281 An in vitro model for tumor cell - stromal cell crosstalk in ovarian cancer. Induction of uPA gene expression in stromal cells involves multiple signaling molecules, and is augmented by a 3D extra-cellular matrix

Plasminogen activators and plasminogen activator inhibitors in blood and tumour fluids of patients with ovarian cancer

Endometrial TIMP-4 mRNA is high at midcycle and in hyperplasia, but down-regulated in malignant tumours. Coordinated expression with MMP-26

Transvaginal ultrasound and lactate dehydrogenase isoenzyme activity profile in uterine aspirate for diagnosis of endometrial carcinoma in women with postmenopausal bleeding

Health-related quality of life and functional vision in individuals with retinoblastoma treated with ocular prothesis

Human uterine fluid, examined in undiluted samples for osmolarity and the concentrations of inorganic ions, albumin, glucose, and urea

Cell membrane receptors for urokinase plasminogen activator are increased in malignant ovarian tumours

Progesterone regulation of plasminogen activator inhibitor 1 (PAI-1) antigen and mRNA levels in human endometrial stromal cells

O157 The membrane bound G-protein coupled receptor, GPR30, mediates the anti-invasive effect of estradiol in ovarian cancer cells

Soluble receptor for urokinase plasminogen activator in both full-length and a cleaved form is present in high concentration in cystic fluid from ovarian cancer

Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI‐1)

High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI‐2) is an independent marker for shorter progression‐free survival in patients with early stage endometrial cancer

Fluid characteristics of benign ovarian cysts: correlation with recurrence after puncture

Degradation of urokinase plasminogen activator (UPA) in endometrial stromal cells requires both the UPA receptor and the low-density lipoprotein receptor-related protein/alpha2-macroglobulin receptor

Paracrine Stimulation of Capillary Endothelial Cell Migration by Endometrial Tissue Involves Epidermal Growth Factor and Is Mediated Via Up-Regulation of the Urokinase Plasminogen Activator Receptor

Suchergebnisse filtern